HHLA2 and ovarian cancer: In our study, the MTT assay and EdU staining assay showed that HHLA2-overexpressing ovarian cancer cells exhibited decreased proliferation ability compared with the normal groups, indicating that HHLA2 can inhibit the proliferation of ovarian cancer cells independent of an immune environment.